Skip to content

Clinical trials

Amyloid Neuropathies, Familial trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloid Neuropathies, Familial Country / region: Brazil Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20133
20141
20151
20161
20191
20201
20212
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Alnylam Pharmaceuticals3
Eidos Therapeutics, a BridgeBio company3
Ionis Pharmaceuticals, Inc.2
Beneficência Portuguesa de São Paulo1
Intellia Therapeutics1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloid Neuropathies, Familial15
Amyloidosis13
Alzheimer Disease6
Polyneuropathies5
Amyloidosis, Familial4
Amyloid Neuropathies3
Cardiomyopathies2
Heart Diseases2
Disease1
Genetic Diseases, Inborn1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.